Sowell Financial Services’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-179
Closed -$7K 2300
2021
Q1
$7K Buy
179
+161
+894% +$6.33K ﹤0.01% 2477
2020
Q4
$0 Hold
18
﹤0.01% 2836
2020
Q3
$0 Hold
18
﹤0.01% 2683
2020
Q2
$0 Hold
18
﹤0.01% 2637
2020
Q1
$0 Hold
18
﹤0.01% 2656
2019
Q4
$0 Hold
18
﹤0.01% 2639
2019
Q3
$0 Buy
+18
New +$23 ﹤0.01% 2447

Other funds holding FLNA

Sowell Financial Services's FLNA Position: Q2 2021 in Review

Sowell Financial Services sold out of Filana Therapeutics (FLNA) in Q2 2021, closing a stake of 179 shares — an estimated $7K sold.

Sowell Financial Services first reported a position in FLNA in Q3 2019 and held it in 7 quarters. The position peaked at $7K in Q1 2021. 169 funds tracked by Wall St. Rank hold FLNA as of Q2 2021.

  • Sowell Financial Services reported no remaining Filana Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 179 Filana Therapeutics shares in Q2 2021, an estimated $7K.
  • Sowell Financial Services first reported a position in Filana Therapeutics in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Filana Therapeutics position peaked at $7K in Q1 2021.
  • 169 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.